When Using DOPPS Slides

DOPPS Slide Use Guidelines

The Survival Advantage for Hemodialysis Patients taking Vitamin D is Questioned: Findings from the Dialysis Outcomes and Practice Patterns Study

Introduction

DOPPS Background

Figure 1. Percentage of patients prescribed vitamin D and route of vitamin D administration in DOPPS countries at each study phase

Figure 2. Facility-level prescription of Vitamin D, by Region and Phase of DOPPS

Table 1. Patient characteristics and baseline laboratory values according to vitamin D prescription at study entry and adjusted odds ratio (AOR) for vitamin D prescription

Table 1 (cont.)

Table 2. Factors significantly associated with vitamin D initiation and cessation

Table 2 (cont.)

Table 3. Patient characteristics at facilities with vitamin D prescription below or above the regional median a

Table 3 (cont.)

Table 4. Mortality risk and vitamin D prescription

Summary

Summary (cont.)

Acknowledgements